AVI Polymers Ltd delivered a strong Q3FY26 turnaround with revenue up 348% QoQ and net profit rising 206%, supported by growth momentum and rights issue approval.

AVI Polymers Ltd reports Strong growth in Q3FY26; Revenue from Operations up 348% Q-o-Q to Rs. 132.32 crore; Net Profit up 206% Q-o-Q to Rs. 7.02 crore

  • Company has received in-principal approval from Bombay Stock Exchange for Rs. 90 crore Right Issue
  • Shareholders in the EGM held on 11 Dec 2025 approved increasing authorized share capital from Rs.6.5 crore to Rs. 100 crore.

Ahmedabad, Gujarat:  31 January 2026: AVI Polymers Ltd (BSE – 539288) a specialty chemicals company engaged in wholesale trading of chemical products, has reported a remarkable operational turnaround in Q3 FY26. The December 2025 quarter marks a dramatic resurgence for AVI.

Company has reported a net profit of Rs. 7.02 crore in Q3FY26 ended 31st December as compared to the net profit of Rs. 2.29 crore in Q2FY26, up 206% Q-o-Q. The micro-cap company reported Revenue from operations of Rs. 132.32 crore in Q3FY26 as against revenue of Rs. 29.50 crore in Q2FY26 registering strong 348% growth Q-o-Q. 

Company has recently secured BSE's in-principle approval for its Rs 90 crore rights issue, issued on January 06, 2026. The approval allows the company to proceed with its fundraising initiative while meeting specific compliance requirements including record date notifications and price disclosures.

For Nine month of FY25-26, company has reported net profit of Rs. 10.09 crore and Revenue from operations of Rs. 161.82 crore.

Sharing more details, Mr. Chintan Patel, Managing Director, AVI Polymers Ltd, said, “Q3 FY26 marks a decisive turnaround for the company, reflecting the strength of our execution, disciplined cost management, and renewed business momentum. The sharp growth in revenue and profitability underscores the scalability of our trading platform and growing customer confidence. The in-principle approval for the 90 crore Rights Issue is a critical milestone and will provide the necessary growth capital to expand volumes, strengthen working capital, and pursue strategic opportunities. With shareholder support and a strengthened capital base, we are well-positioned to accelerate sustainable growth and create long-term value.”

The Board of Directors have recently approved raising funds up to Rs 90.00 crore through a rights issue of equity shares, each with a face value of Rs 10.00. The company plans to issue equity shares to eligible shareholders, with an authorized Allotment Committee finalizing the detailed terms and conditions. Company will announce more details of the rights issue in the forthcoming board meeting including, term of Rights Issue including Equity shares to be offered through the issue, issue price per equity share, Right entitlement ratio, Terms of Payment, etc. Record date, timing of the Rights Issue and other matters incidental or connected therewith.

In the Extra Ordinary General Meeting held on 11 December 2025, shareholders of AVI Polymers has approved increasing authorized share capital from Rs.6.5 crore to Rs. 100 crore. The approved restructuring increases the company's authorized share capital to Rs. 100 crore, expanding the number of equity shares from 65 lakh to 10 crore while maintaining the face value of Rs. 10 per share.

Shareholders also unanimously approved the appointment of M/s Kapil Kumar Agrawal Associates as the company's statutory auditors, receiving 100.00% votes in favor across all categories.

The substantial increase in authorized share capital positions AVI Polymers for potential future growth initiatives, capital raising activities, or strategic expansions. The unanimous shareholder approval reflects strong confidence in the company's management and strategic direction. The appointment of new statutory auditors ensures continued compliance with regulatory requirements and corporate governance standards.

(Disclosures: At the time of writing this article, author, his clients & dependent family members may have positions in the stocks mentioned above. The author, his firm, his clients or any of his dependent family members may make purchases or sale of the securities mentioned in website. Author may have positions in above stocks so have vested interest obviously in their going up or down as the case may be.

Disclaimer: Investing in any equity is risky. Our recommendations are based on reliable & authenticated sources believed to be true & correct, and also is technical analysis based on & conceived from charts. Investors should take their own decisions. We assume no responsibility for any transactions undertaken by them. The author won't be liable or responsible for any legal or financial losses made by anybody. Investors must take advice from their financial advisors before investing in any stocks.)

 

Visitors : HTML Hit Counters